Multigenerational epigenetic effects of nicotine on lung function

Multigenerational epigenetic effects of nicotine on lung function

<p>Abstract</p> <p>A recent preclinical study has shown that not only maternal smoking but also grandmaternal smoking is associated with elevated pediatric asthma risk. Using a well-established rat model of <it>in utero </it>nicotine exposure, Rehan <it>et al</...

Full description

Bibliographic Details
Main Author:	Leslie Frances M
Format:	Article
Language:	English
Published:	BMC 2013-02-01
Series:	BMC Medicine
Subjects:	development DNA methylation histone acetylation nicotine replacement therapy (NRT) peroxisome proliferator-activated receptor-γ (PPARγ) smoking tobacco
Online Access:	http://www.biomedcentral.com/1741-7015/11/27

Similar Items

Smoking cessation strategies: An in-depth analysis of nicotine replacement therapy and alternatives
by: Łukasz Mrozek, et al.
Published: (2023-08-01)

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches
by: M S Rasin
Published: (2013-09-01)

Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 gene on lipid profile and adipokines levels in obese subjects
by: Becer E, et al.
Published: (2017-06-01)

Dexmedetomidine ameliorates hyperalgesia of rat models with neuropathic pain via upregulation of PPAR-γ
by: ZHU Feng, ZHONG Yue, DENG Yijiang, LIU Wenzhi, BIAN Jiang
Published: (2023-09-01)

PPAR𝛾 gene and atherosclerosis: Genetic polymorphisms, epigenetics and therapeutic implications
by: Grbić E, et al.
Published: (2018-10-01)

Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism
by: Jia Liu, et al.
Published: (2022-04-01)

In vivo Experience With NRT to Increase Adherence and Smoking Abstinence Among Individuals in the Criminal Legal System: Study Protocol for a Randomized Clinical Trial
by: Elizabeth S. Hawes, et al.
Published: (2022-06-01)

Reno-protective effect of mangiferin against methotrexate-induced kidney damage in male rats: PPARγ-mediated antioxidant activity
by: Seba Hassan Attia, et al.
Published: (2022-09-01)

Tobacco smoking cessation management: integrating varenicline in current practice
by: Laurence M Galanti
Published: (2008-08-01)

Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
by: Xiaojing Zhang, et al.
Published: (2022-12-01)

Inverse Relationship between 15-Lipoxygenase-2 and PPAR-γ Gene Expression in Normal Epithelia Compared with Tumor Epithelia
by: Vemparala Subbarayan, et al.
Published: (2005-03-01)

Down-regulation of miR-27a alleviates lung injury in septic rat models
by: LI Jia-jin, LIU Jun, HE Song-yu, CHEN Hao-yun
Published: (2022-11-01)

PPARγ-Induced Global H3K27 Acetylation Maintains Osteo/Cementogenic Abilities of Periodontal Ligament Fibroblasts
by: Hang Yuan, et al.
Published: (2021-08-01)

Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)
by: Susanne Back, et al.
Published: (2023-03-01)

Simvastatin-romidepsin combination kills bladder cancer cells synergistically
by: Kazuki Okubo, et al.
Published: (2021-09-01)

Insights into the pathogenesis of nicotine addiction. Could a salivary biosensor be useful in Nicotine Replacement Therapy (NRT)?
by: Anida-Maria Băbțan, et al.
Published: (2019-10-01)

Structural basis of the activation of PPARγ by the plasticizer metabolites MEHP and MINCH
by: Abibe Useini, et al.
Published: (2023-03-01)

Transdifferentiation of bovine epithelial cells towards adipocytes in the presence of myoepithelium
by: Subi Sugathan, et al.
Published: (2020-02-01)

Di-(2-ethylhexyl) phthalate substitutes accelerate human adipogenesis through PPARγ activation and cause oxidative stress and impaired metabolic homeostasis in mature adipocytes
by: Alexandra Schaffert, et al.
Published: (2022-06-01)

Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-γ activation
by: Wei-Hsuan Hsu, et al.
Published: (2013-01-01)

<i>Pparγ1</i> Facilitates ErbB2-Mammary Adenocarcinoma in Mice
by: Xuanmao Jiao, et al.
Published: (2021-04-01)

Editorial: Immunology and immunopathogenesis of human leishmaniasis
by: Juliana P. B. de Menezes, et al.
Published: (2022-10-01)

Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation
by: Alexandra Schaffert, et al.
Published: (2021-11-01)

SIRT7 regulates lipogenesis in adipocytes through deacetylation of PPARγ2
by: Fatema Akter, et al.
Published: (2021-10-01)

Epigenetic Histone Methylation of PPARγ and CPT1A Signaling Contributes to Betahistine Preventing Olanzapine-Induced Dyslipidemia
by: Yueqing Su, et al.
Published: (2023-05-01)

Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells
by: Shadi Esmaeili, et al.
Published: (2023-03-01)

Corrigendum: Peroxisome proliferator–activated receptor-α: A pivotal regulator of the gastrointestinal tract
by: Yue-Xin Guo, et al.
Published: (2022-10-01)

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
by: Yongyan Song, et al.
Published: (2022-03-01)

Offering nicotine patches to all households in a community with high smoking rates: Pilot test of a population-based approach to promote tobacco cessation
by: John A Cunningham, et al.
Published: (2021-02-01)

Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway
by: Huixia Lu, et al.
Published: (2017-11-01)

The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
by: Giuseppina Augimeri, et al.
Published: (2020-09-01)

Whey protein powder with milk fat globule membrane attenuates Alzheimer's disease pathology in 3×Tg-AD mice by modulating neuroinflammation through the peroxisome proliferator-activated receptor γ signaling pathway
by: Yu Li, et al.
Published: (2023-08-01)

PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01)

Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist
by: Hiroyuki Miyachi
Published: (2023-02-01)

Impact of Proliferator-Activated Receptor γ Gene Polymorphisms on Risk of Schizophrenia: A Case-Control Study and Computational Analyses
by: Saman Sargazi, et al.
Published: (2020-09-01)

Crtc1 Deficiency Causes Obesity Potentially via Regulating PPARγ Pathway in White Adipose
by: Yimeng Hu, et al.
Published: (2021-04-01)

E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT
by: Peter Hajek, et al.
Published: (2019-08-01)

Factors associated with quitting among smoking cessation medication-assisted smokers and ex-smokers: A cross-sectional study in Australia
by: Amanual Getnet Mersha, et al.
Published: (2023-04-01)

Long-term effectiveness of mailed nicotine replacement therapy: study protocol of a randomized controlled trial 5-year follow-up
by: Vladyslav Kushnir, et al.
Published: (2017-07-01)

Nicotine Impairs the Anti-Contractile Function of Perivascular Adipose Tissue by Inhibiting the PPARγ–Adiponectin–AdipoR1 Axis
by: Afifah Zahirah Abd Rami, et al.
Published: (2023-10-01)